Europe — EMA
Ondansetron Fresenius Kabi (Ondansetron Hydrochloride Dihydrate)
Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as an intravenous solution for IV use.
Request sourcing
What is Ondansetron Hydrochloride Dihydrate?
Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as an intravenous solution for IV use. It helps prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
GNH USA supplies Ondansetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Ondansetron Hydrochloride Dihydrate used for?
Ondansetron Fresenius Kabi is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting associated with several clinical pathways.
- Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes. - Radiotherapy‑induced nausea and vomiting: helps control nausea during and after radiation treatment. - Post‑operative nausea and vomiting: decreases the incidence of vomiting after surgical procedures. - Pregnancy‑related hyperemesis gravidarum (off‑label): may be used when conventional therapy fails, under specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist.
What are the side effects of Ondansetron Hydrochloride Dihydrate?
Common Side Effects: - g t ewline ewline ... .... ewline ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
Serious or Rare t ewline \\
